BeStock  
Stocks › Biotechnology › MLYS

Mineralys Therapeutics MLYS

US equityMarket cap rank #3034Biotechnology
$13.66 −$0.50 (-3.53%)
Market closed · Nov 20, 8:20 pm ET · Last extended-hours $13.70 +0.29%
Open$13.81
Prev close$14.16
Day range$13.57 – $14.79
Volume1.35M
Market cap$1.21B
P/E (TTM)–
Dividend yield–

Earnings

Average move on report day±6.0%last 16 reports
Closed higher5 of 1631% of the time
Best reaction+10.0%
Worst reaction-22.8%

Stock move on the day after each report

-2.2%2023/Q4-2.6%2024/Q1-22.8%2024/Q2-10.3%2024/Q3+10.0%2024/Q4+1.2%2025/Q1+0.4%2025/Q2+5.9%2025/Q3-3.0%2025/Q4-2.6%2026/Q1-1.0%2026/Q2-10.4%2026/Q3
QuarterReport dateTimingImplied moveActual moveVersus implied
2026/Q34 Nov 2026After Market±20.0%-10.35%Within range
2026/Q211 Aug 2026After Market±7.5%-1.02%Within range
2026/Q16 May 2026After Market±13.3%-2.56%Within range
2025/Q412 Mar 2026After Market±12.2%-2.96%Within range
2025/Q310 Nov 2025After Market±10.3%+5.87%Within range
2025/Q212 Aug 2025After Market±17.4%+0.37%Within range
2025/Q112 May 2025After Market±12.3%+1.20%Within range
2024/Q412 Feb 2025Pre Market–+10.04%–
2024/Q311 Nov 2024After Market–-10.32%–
2024/Q213 Aug 2024After Market±37.6%-22.82%Within range
2024/Q19 May 2024Pre Market±32.0%-2.59%Within range
2023/Q421 Mar 2024Pre Market–-2.24%–
2023/Q37 Nov 2023After Market–-6.74%–
2023/Q27 Aug 2023After Market–+6.96%–
2023/Q115 May 2023After Market–-4.57%–
2022/Q415 Mar 2023After Market–-5.93%–

"Implied move" is the size of move the options market was pricing ahead of the report. Move is the stock’s change on the first session after the release.

Latest reported quarter: Q3, ended Sep 2026

Revenue$0.00
Operating profit-$60.09M-46.1% YoY
Net profit-$57.33M-55.2% YoY
Diluted EPS-$0.64-23.1% YoY
Free cash flow-$43.10M-49.3% YoY
Operating cash flow-$43.10M

Revenue, last 8 quarters

$0.0Dec '24$0.0Mar '25$0.0Jun '25$0.0Sep '25$0.0Dec '25$0.0Mar '26$0.0Jun '26$0.0Sep '26

Net profit, last 8 quarters

$-48.9MDec '24$-42.2MMar '25$-43.3MJun '25$-36.9MSep '25$-32.2MDec '25$-39.3MMar '26$-241.1MJun '26$-57.3MSep '26

Profitability & balance sheet

Return on equity-68.5%
Return on assets-60.2%
Return on invested capital-61.7%
Current ratio11.83
Liabilities / assets20.1%
Cash & investments$624.67M
Total debt$98.27M
Net cash (debt)$526.40M

Discussion

No comments yet — be the first to weigh in on MLYS.

Sign in to join the discussion.

Scroll to Top